4//SEC Filing
SHOVLIN ROBERT J. 4
Accession 0001077183-20-000171
CIK 0001077183other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 7:26 PM ET
Size
14.5 KB
Accession
0001077183-20-000171
Insider Transaction Report
Form 4
SHOVLIN ROBERT J.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2020-07-30$7.52/sh+66,667$501,336→ 212,902 total - Sale
Common Stock
2020-07-30$38.17/sh−81,356$3,105,359→ 148,270 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-30−66,667→ 0 totalExercise: $7.52Exp: 2022-04-28→ Common Stock (66,667 underlying) - Exercise/Conversion
Common Stock
2020-07-30$19.60/sh+16,724$327,790→ 229,626 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-30−16,724→ 50,173 totalExercise: $19.60Exp: 2024-03-01→ Common Stock (16,724 underlying)
Holdings
- 56,271
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (56,271 underlying) - 96,167
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (96,167 underlying)
Footnotes (4)
- [F1]On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001621453
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 7:26 PM ET
- Size
- 14.5 KB